Langenbeck's Archives of Surgery

, Volume 392, Issue 4, pp 431–435 | Cite as

Rare normalization of blood pressure after unilateral adrenalectomy in 31 patients with Conn syndrome

  • Jacek ZiajaEmail author
  • Jerzy Chudek
  • Robert Król
  • Jacek Pawlicki
  • Andrzej Więcek
  • Lech Cierpka
Original Article



Adrenal tumor excision in patients with Conn syndrome is not always followed by normalization of blood pressure (BP). The aim of the study was to determine predictors of persistent hypertension during long-term observation after adrenalectomy.

Materials and methods

Thirty-one patients (23 F and 8 M) with Conn syndrome and adrenal tumor subjected to unilateral adrenalectomy were included. The duration of hypertension ranged from 1 to 30 years and observation time from 1 to 10 years.


Beneficial impact of adrenalectomy on BP control was found in 25 patients, including only 10 patients with BP normalization. Patients with normalization of BP were significantly younger [41 (36–46) vs 53 (48–57) years; p = 0.002] and had lower pulse BP [72 (56–89) vs 93(80–106) mmHg; p = 0.03]. Significant decline of maximal values of systolic and diastolic BP after surgery was observed [59 (47–72) and 29 (20–37) mmHg, respectively]. The analysis revealed that age over 50 years and pulse BP over 70 mmHg predict the persistence of hypertension after surgery.


Normalization of BP after adrenalectomy is observed only in 32% of patients with Conn syndrome regardless the normalization of hypokalemia. BP normalization in long period observation was more frequently found in younger patients with lower pulse BP.


Conn syndrome Primary hyperaldosteronism Arterial hypertension Adrenocortical adenoma Adrenalectomy 


  1. 1.
    Januszewicz W (1999) Postępy w diagnostyce i leczeniu nadciśnienia tętniczego wtórnego. Terapia 9:11–16Google Scholar
  2. 2.
    Young WF Jr (2003) Minireview: primary aldosteronism—changing concepts in diagnosis and treatment. Endocrinology 144:2208–2213PubMedCrossRefGoogle Scholar
  3. 3.
    Weigel RJ, Wells SA, Gunnells JC, Leight GS (1994) Surgical treatment of primary hyperaldosteronism. Ann Surg 219:347–352PubMedCrossRefGoogle Scholar
  4. 4.
    Feltynowski T, Wocial B, Chodakowska J, Pruszczyk P, Kulicka D, Tatar J, Ignatowska-Świtalska H, Osikowska-Loksztejn M, Januszewicz W (1991) Ciśnienie tętnicze u chorych po jednostronnej adrenalektomii z powodu gruczolaka kory nadnerczy wytwarzającego aldosteron. Polski Tygodnik Lekarski 35–36:649–651Google Scholar
  5. 5.
    Obara T, Ito Y, Okamoto T, Kanaji Y, Yamashita T, Aiba M, Fujimoto Y (1992) Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 112:987–993PubMedGoogle Scholar
  6. 6.
    Sapienza P, Cavallaro A (1999) Persistent hypertension after removal of adrenal tumours. Eur J Surg 165:187–192PubMedCrossRefGoogle Scholar
  7. 7.
    Ziaja J, Cierpka L, Król R, Gasińska T, Tuszyński G, Cholewa K, Kajor M (2003) Wpływ adrenalektomii na leczenie nadciśnienia tętniczego u chorych z łagodnymi guzami rdzenia i kory nadnerczy. Wiadomości Lekarskie 56(11–12):545–551PubMedGoogle Scholar
  8. 8.
    Grady RW, Kaylor WM, Lee J-C, Bravo EL, Gephardt GN, Novick AC (1996) Renal pathology in patients with primary hyperaldosteronism secondary to an adrenal cortical adenoma. Urology 48:369–372PubMedCrossRefGoogle Scholar
  9. 9.
    Favia G, Lumachi F, Scarpa V, D’Amico DF (1992) Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients. World J Surg 16:680–684PubMedCrossRefGoogle Scholar
  10. 10.
    Puccini M, Iacconi P, Bernini G, Miccoli P, Lynn JA (1998) Conn syndrome: 14 year’s experience from two European centres. Eur J Surg 164:811–817PubMedCrossRefGoogle Scholar
  11. 11.
    Siren J, Valimaki M, Huikuri K, Sivula A, Voutilainen P, Haapiainen R (1998) Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients. World J Surg 22:418–422PubMedCrossRefGoogle Scholar
  12. 12.
    Rutherford JC, Taylor WL, Stowasser M, Gordon RD (1998) Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production. World J Surg 22:1243–1245PubMedCrossRefGoogle Scholar
  13. 13.
    World Health Organization (1999) World Health Organization International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee (1999). J Hypertens 17:151–183Google Scholar
  14. 14.
    Kass DA (2005) Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 46:185–193PubMedCrossRefGoogle Scholar
  15. 15.
    Abrams WB (1998) Pathophysiology of hypertension in older patients. Am J Med 85:7–13CrossRefGoogle Scholar
  16. 16.
    Torpy DJ, Stratakis CA, Chrousos GP (2000) Familial hyperaldosteronism. Braz J Med Biol Res 33:1149–1155PubMedCrossRefGoogle Scholar
  17. 17.
    Garrison RJ, Kannel WB, Stokes J III, Castelli WP (1987) Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 16:235–251PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Jacek Ziaja
    • 1
    Email author
  • Jerzy Chudek
    • 2
  • Robert Król
    • 1
  • Jacek Pawlicki
    • 1
  • Andrzej Więcek
    • 2
  • Lech Cierpka
    • 1
  1. 1.Department of General, Vascular and Transplant SurgeryMedical University of SilesiaKatowicePoland
  2. 2.Department of Nephrology, Endocrinology and Metabolic DiseasesMedical University of SilesiaKatowicePoland

Personalised recommendations